BioCentury
ARTICLE | Clinical News

BIO-11006 Inhalation Solution: Phase I data

February 11, 2008 8:00 AM UTC

In a double-blind, placebo-controlled Phase I trial (BIM-CL-001) in 8 volunteers, single doses of BIO-11006 were safe and well tolerated. The company plans to begin a Phase II trial in COPD patients w...